Search Results 81-90 of 17060 for ulcerative colitis
A Study to Assess the Effectiveness and Safety of Golimumab in Pediatric Participants With Moderately-to-Severely Active Ulcerative Colitis · Overview.
AMG 181 Phase 2 Study in Subjects with Moderate to Severe Ulcerative Colitis. Print details. Share; Facebook · Twitter. Overview; Participation eligibility ...
Six of the seven patients in the chart review were diagnosed with Crohn's disease and one was diagnosed with ulcerative colitis. Three patients were treated ...
A Study of the Effect of Vedolizumab in Conjunction with Structured Semi-Vegetarian Diet on the Treatment of Ulcerative Colitis · Overview · Participation ...
Ulcerative colitis and Crohn's disease are the two main types. Marissa began experiencing symptoms of inflammatory bowel disease when she was in her early ...
... ulcerative colitis (UC) or Crohn's disease (CD) to advance biomarker research that might one day improve diagnosis, prognosis and treatment of IBD.
Dealing with chronic conditions like Crohn's disease and ulcerative colitis can be challenging and sometimes embarrassing. Inflammatory bowel disease (IBD) ...
The purpose of this study is to evaluate the safety, tolerability and microbiome dynamics of SER-287 in subjects with mild-to-moderate ulcerative colitis.
Rectal corticosteroids are used to treat mild or moderate ulcerative colitis. They also may be used along with systemic (oral or injection) corticosteroids or ...
A Long-Term Registry of Humira® (Adalimumab) in Patients With Moderately to Severely Active Ulcerative Colitis (UC) · More about research at Mayo Clinic · Mayo ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make your tax-deductible gift and be a part of the cutting-edge research and care that's changing medicine.